All In MedTech

Device Trial Radar · NCT01290068

Visual Outcomes After Cataract Surgery: Multifocal AcrySof® IQ ReSTOR® Intraocular Lenses Versus Monofocal Intraocular Lenses

Visual Outcomes After Bilateral Surgical Cataract Phacoemulsification: AcrySof® ReSTOR IOL Implantation Compared to Monofocal IOL Implantation

Last checked: Nov 20, 2026Latest source record: Jul 2, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 208 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

208

Actual

Start

Apr 2011

Primary completion

Oct 2012

Study completion Oct 2012

Sponsor

Lead sponsor
Alcon ResearchNot on our public-company list
Sponsor type
Industry
First posted
Feb 4, 2011

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess and compare visual outcomes of the AcrySof® IQ ReSTOR® +3.0 D intraocular lens (IOL) to a commercially available monofocal IOL in cataract patients.

Conditions

  • Cataract

Interventions

  • AcrySof® IQ ReSTOR® +3.0 D Multifocal IOLDevice

    Multifocal IOL with extended secondary focal point implanted for long-term use over the lifetime of the cataract patient

  • AcrySof® IQ ReSTOR® +3.0 D Multifocal Toric IOLDevice

    Multifocal IOL with extended secondary focal point and astigmatism correction implanted for long-term use over the lifetime of the cataract patient

  • Monofocal IOLDevice

    Monofocal IOL implanted for long-term use over the lifetime of the cataract patient

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Classified as RespondersTime frame: Month 6 after second eye implantation
  2. Proportion of Participants Reporting Spectacle Independence at All DistancesTime frame: Month 6 after second eye implantation
  3. Mean Vision-Related Quality of Life as Reported on the NEI-RQL 42 (5 Dimensions)Time frame: Month 6 after second eye implantation

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.